Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 4,949 $ 1,769
Restricted cash 25,680  
Accounts receivable, net 1,726 2,150
Inventories, net 7,422 7,971
Investment in marketable securities   27,929
Prepaid expenses and other current assets 1,117 1,402
Total current assets 40,894 41,221
Property and equipment, net 130 151
Equity method investment 14,484 13,325
Right of use assets 4,145 4,474
Deposits and other assets 291 285
Total assets 59,944 59,456
CURRENT LIABILITIES    
Accounts payable and accrued expenses 7,675 11,498
Operating lease liabilities, current portion 1,100 991
Other current liabilities 1,934 5,748
Revolving line of credit to related parties, net 800 600
Warrant derivative liabilities 794 38
Notes payable, current portion 4,452 3,749
Notes payable to related parties 816 193
Convertible debentures, net of discount 6,209 7,015
Convertible note payable, net of discount   2,995
Total current liabilities 23,780 32,827
Operating lease liabilities, less current portion 3,588 3,932
Other long-term liabilities 35,436 33,750
Notes payable, less current portion 355  
Convertible note payable 3,150  
Total long-term liabilities 42,529 37,682
Total liabilities 66,309 70,509
STOCKHOLDERS’ DEFICIT    
Preferred stock — par value $0.001 per share, 15,000,000 shares authorized, none issued or outstanding
Common stock — par value $0.001 per share, 250,000,000 shares authorized, 48,987,189 shares and 48,471,446 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 49 48
Additional paid-in capital 218,484 215,207
Accumulated other comprehensive loss (86) (79)
Accumulated deficit (224,812) (226,229)
Total stockholders’ deficit (6,365) (11,053)
Total liabilities & stockholders’ deficit $ 59,944 $ 59,456